Home / Latest Reports / Pharmacovigilance Market

Pharmacovigilance Market By Clinical Trial Phase, Service Provider, Type and End User - Global Industry Analysis & Forecast to 2027

Published On : January 2019 Pages : 160 Category: Pharma & Healthcare Report Code : HC012428

Request Sample Inquiry Before Buying Request for Customization Check Discount

Pharmacovigilance Market By Clinical Trial Phase (Pre-clinical, Phase I, Phase II, Phase III and Phase IV), Service Provider (In-house and Contract Outsourcing), Type (Intensified ADR Reporting, Targeted Spontaneous Reporting, Spontaneous Reporting, EHR Mining and Cohort Event Monitoring) and End User (Research Organizations, Hospitals and Industrial) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Pharmacovigilance Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Expanding rate of Adverse Drug Reactions (ADRs) is anticipated to quicken the interest for pharmacovigilance services over the conjecture time frame. Developing prevalence of chronic diseases is another significant benefactor for the PV development. Treatment of these chronic diseases require uptake of blend of medications bringing about ADR. To curtail this issue, PV administrations are used. Also, presence of charitable association for spreading the awareness associated with PV, for example, International Society of Pharmacovigilance (ISoP) is anticipated to encourage the selection of PV amid the conjecture time frame as it is concentrating on upgrading safe and appropriate use of medications at worldwide level. Increasing government activities relating to adoption of PV administrations is foreseen to impel the business development in the following years.

Market Segmentation

The Pharmacovigilance Market is based on different segments namely by clinical trial into phase pre-clinical, phase i, phase ii, phase iii and phase iv; by service provider into in-house and contract outsourcing; by type into intensified ADR reporting, targeted spontaneous reporting, spontaneous reporting, EHR mining and cohort event monitoring;  by end user into research organizations, hospitals and industrial.

Pharmacovigilance Market By Clinical Trial Phase

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Pharmacovigilance Market By Service Provider

  • In-house
  • Contract Outsourcing

Pharmacovigilance Market By Type

  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Spontaneous Reporting
  • EHR Mining
  • Cohort Event Monitoring

Pharmacovigilance Market By End User

  • Research Organizations
  • Hospitals
  • Industrial

Regional Insights

On a global front, the Pharmacovigilance Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North America captured the biggest revenue share in 2017, attributable to presence of key pharmaceutical and medicinal devices players in this area, adding to the general income in this area.

  • Pharmacovigilance Market, By Region
    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are BioClinica, LabCorp, Capgemini, Clinquest Group B.V, iMEDGlobal, ITClinical, Cognizant, ArisGlobal LLC, ICON plc, IBM and Accenture. This industry is witnessing a tremendous boost due to patent expiration of branded drugs and rising number of new drug developments. This has encouraged several local and international pharmacovigilance service providers in the market.

  • BioClinica
  • LabCorp
  • Capgemini
  • Clinquest Group B.V
  • iMEDGlobal
  • ITClinical
  • Cognizant
  • ArisGlobal LLC
  • ICON plc
  • IBM
  • Accenture

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Pharmacovigilance Market, By Clinical Trial Phase, Estimates and Forecast, 2014-2023 ($Million)

·         Pre-clinical

·         Phase I

·         Phase II

·         Phase III

·         Phase IV

·         Pharmacovigilance Market, By Service Provider, Estimates and Forecast, 2014-2023 ($Million)

·         In-house

·         Contract Outsourcing

·         Pharmacovigilance Market, By Type, Estimates and Forecast, 2014-2023 ($Million)

·         Intensified ADR Reporting

·         Targeted Spontaneous Reporting

·         Spontaneous Reporting

·         EHR Mining

·         Cohort Event Monitoring

·         Pharmacovigilance Market, By End User, Estimates and Forecast, 2014-2023 ($Million)

·         Research Organizations

·         Hospitals

·         Industrial

·         Pharmacovigilance Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

o    North America

§  North America Pharmacovigilance Market, By Country

o    U.S. Pharmacovigilance Market

o    Canada Pharmacovigilance Market

o    Mexico Pharmacovigilance Market

o    Europe

§  Europe Pharmacovigilance Market, By Country

o    Germany Pharmacovigilance Market

o    UK Pharmacovigilance Market

o    France Pharmacovigilance Market

o    Russia Pharmacovigilance Market

o    Italy Pharmacovigilance Market

o    Rest of Europe Pharmacovigilance Market

o    Asia-Pacific

§  Asia-Pacific Pharmacovigilance Market, By Country

o    China Pharmacovigilance Market

o    Japan Pharmacovigilance Market

o    South Korea Pharmacovigilance Market

o    India Pharmacovigilance Market

o    Southeast Asia Pharmacovigilance Market

o    Rest of Asia-Pacific Pharmacovigilance Market

o    South America

§  South America Pharmacovigilance Market

o    Brazil Pharmacovigilance Market

o    Argentina Pharmacovigilance Market

o    Columbia Pharmacovigilance Market

o    Rest of South America Pharmacovigilance Market

o    Middle East and Africa

§  Middle East and Africa Pharmacovigilance Market

o    Saudi Arabia Pharmacovigilance Market

o    UAE Pharmacovigilance Market

o    Egypt Pharmacovigilance Market

o    Nigeria Pharmacovigilance Market

o    South Africa Pharmacovigilance Market

o    Rest of MEA Pharmacovigilance Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Pharmacovigilance  Market, By Clinical Trial Phase

5.1.     Introduction

5.2.     Global Pharmacovigilance  Revenue and Market Share by Clinical Trial Phase (2017-2027)

5.2.1.  Global Pharmacovigilance  Revenue and Revenue Share by Clinical Trial Phase (2017-2027)

5.3.     Pre-clinical

5.3.1.  Global Pre-clinical Revenue and Growth Rate (2017-2027)

5.4.     Phase I

5.4.1.  Global Phase I Revenue and Growth Rate (2017-2027)

5.5.     Phase II

5.5.1.  Global Phase II Revenue and Growth Rate (2017-2027)

5.6.     Phase III

5.6.1.  Global Phase III Revenue and Growth Rate (2017-2027)

5.7.     Phase IV

5.7.1.  Global Phase IV Revenue and Growth Rate (2017-2027)

6.       Pharmacovigilance  Market, By Service Provider

6.1.     Introduction

6.2.     Global Pharmacovigilance  Revenue and Market Share by Service Provider  (2017-2027)

6.2.1.  Global Pharmacovigilance  Revenue and Revenue Share by Service Provider  (2017-2027)

6.3.     In-house

6.3.1.  Global In-house Revenue and Growth Rate (2017-2027)

6.4.     Contract Outsourcing

6.4.1.  Global Contract Outsourcing Revenue and Growth Rate (2017-2027)

7.       Pharmacovigilance  Market, By Type

7.1.     Introduction

7.2.     Global Pharmacovigilance  Revenue and Market Share by Type  (2017-2027)

7.2.1.  Global Pharmacovigilance  Revenue and Revenue Share by Type  (2017-2027)

7.3.     Intensified ADR Reporting

7.3.1.  Global Intensified ADR Reporting Revenue and Growth Rate (2017-2027)

7.4.     Targeted Spontaneous Reporting

7.4.1.  Global Targeted Spontaneous Reporting Revenue and Growth Rate (2017-2027)

7.5.     Spontaneous Reporting

7.5.1.  Global Spontaneous Reporting Revenue and Growth Rate (2017-2027)

7.6.     EHR Mining

7.6.1.  Global EHR Mining Revenue and Growth Rate (2017-2027)

7.7.     Cohort Event Monitoring

7.7.1.  Global Cohort Event Monitoring Revenue and Growth Rate (2017-2027)

8.       Pharmacovigilance  Market, By End User

8.1.     Introduction

8.2.     Global Pharmacovigilance  Revenue and Market Share by End User (2017-2027)

8.2.1.  Global Pharmacovigilance  Revenue and Revenue Share by End User (2017-2027)

8.3.     Research Organizations

8.3.1.  Global Research Organizations Revenue and Growth Rate (2017-2027)

8.4.     Hospitals

8.4.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

8.5.     Industrial

8.5.1.  Global Industrial Revenue and Growth Rate (2017-2027)

9.       Pharmacovigilance  Market, By Region

9.1.     Introduction

9.2.     Global Pharmacovigilance  Revenue and Market Share by Regions

9.2.1.  Global Pharmacovigilance  Revenue by Regions (2017-2027)

9.3.     North America Pharmacovigilance  by Countries

9.3.1.  North America Pharmacovigilance  Revenue and Growth Rate (2017-2027)

9.3.2.  North America Pharmacovigilance  Revenue (Million USD) by Countries (2017-2027)

9.3.3.  United States

9.3.3.1.  United States Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.  Canada Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.  Mexico Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.     Europe Pharmacovigilance  by Countries

9.4.1.  Europe Pharmacovigilance  Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Pharmacovigilance  Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.  Germany Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  France

9.4.4.1.  France Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  UK

9.4.5.1.  UK Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.  Russia Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.  Italy Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.     Asia-Pacific Pharmacovigilance  by Countries

9.5.1.  Asia-Pacific Pharmacovigilance  Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Pharmacovigilance  Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.  China Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.  Japan Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.  Korea Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.  India Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.     South America Pharmacovigilance  by Countries

9.6.1.  South America Pharmacovigilance  Revenue and Growth Rate (2017-2027)

9.6.2.  South America Pharmacovigilance  Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.  Brazil Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.  Argentina Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.  Columbia Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.     Middle East and Africa Pharmacovigilance  by Countries

9.7.1.  Middle East and Africa Pharmacovigilance  Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Pharmacovigilance  Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.  Egypt Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.  South Africa Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Turkey

9.7.8.1.  Turkey Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

10.    Company Profiles

10.1. BioClinica

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. LabCorp

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. Capgemini

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. Clinquest Group B.V

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. iMEDGlobal

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. ITClinical

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. Cognizant

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. ArisGlobal LLC

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

10.9. ICON plc

10.9.1.      Business Overview

10.9.2.       Service Portfolio

10.9.3.      Strategic Developments

10.9.4.       Revenue and Market Share

10.10.                   IBM

10.10.1.  Business Overview

10.10.2.   Service Portfolio

10.10.3.  Strategic Developments

10.10.4.   Revenue and Market Share

10.11.                   Accenture

10.11.1.  Business Overview

10.11.2.   Service Portfolio

10.11.3.  Strategic Developments

10.11.4.   Revenue and Market Share

11.    Global Pharmacovigilance  Market Competition, by Manufacturer

11.1. Global Pharmacovigilance  Revenue and Market Share by Manufacturer (2017-2017)

11.2. Global Pharmacovigilance  Price By Region (2017-2017)

11.3. Top 5 Pharmacovigilance  Manufacturer Market Share

11.4. Market Competition Trend

12.    Pharmacovigilance  Market Forecast (2017-2027)

12.1. Global Pharmacovigilance  Revenue (Millions USD) and Growth Rate (2017-2027)

12.2. Pharmacovigilance  Market Forecast by Regions (2017-2027)

12.2.1.      North America Pharmacovigilance  Market Forecast (2017-2027)

12.2.1.1. United States Pharmacovigilance  Market Forecast (2017-2027)

12.2.1.2. Canada Pharmacovigilance  Market Forecast (2017-2027)

12.2.1.3. Mexico Pharmacovigilance  Market Forecast (2017-2027)

12.2.2.      Europe Pharmacovigilance  Market Forecast (2017-2027)

12.2.2.1. Germany Pharmacovigilance  Market Forecast (2017-2027)

12.2.2.2. France Pharmacovigilance  Market Forecast (2017-2027)

12.2.2.3. UK Pharmacovigilance  Market Forecast (2017-2027)

12.2.2.4. Russia Pharmacovigilance  Market Forecast (2017-2027)

12.2.2.5. Italy Pharmacovigilance  Market Forecast (2017-2027)

12.2.2.6. Rest of Europe Pharmacovigilance  Market Forecast (2017-2027)

12.2.3.      Asia-Pacific Pharmacovigilance  Market Forecast (2017-2027)

12.2.3.1. China Pharmacovigilance  Market Forecast (2017-2027)

12.2.3.2. Japan Pharmacovigilance  Market Forecast (2017-2027)

12.2.3.3. Korea Pharmacovigilance  Market Forecast (2017-2027)

12.2.3.4. India Pharmacovigilance  Market Forecast (2017-2027)

12.2.3.5. Southeast Asia Pharmacovigilance  Market Forecast (2017-2027)

12.2.3.6. Rest of Asia-Pacific Pharmacovigilance  Market Forecast (2017-2027)

12.2.4.      South America Pharmacovigilance  Market Forecast (2017-2027)

12.2.4.1. Brazil Pharmacovigilance  Market Forecast (2017-2027)

12.2.4.2. Argentina Pharmacovigilance  Market Forecast (2017-2027)

12.2.4.3. Columbia Pharmacovigilance  Market Forecast (2017-2027)

12.2.4.4. Rest of South America Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.      Middle East and Africa Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.1. Saudi Arabia Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.2. United Arab Emirates Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.3. Egypt Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.4. Nigeria Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.5. South Africa Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.6. Turkey Pharmacovigilance  Market Forecast (2017-2027)

12.2.5.7. Rest of Middle East and Africa Pharmacovigilance  Market Forecast (2017-2027)

12.3. Pharmacovigilance  Market Forecast by Clinical Trial Phase (2017-2027)

12.3.1.      Pharmacovigilance  Forecast by Clinical Trial Phase (2017-2027)

12.3.2.      Pharmacovigilance  Market Share Forecast by Clinical Trial Phase (2017-2027)

12.4. Pharmacovigilance  Market Forecast by Service Provider  (2017-2027)

12.4.1.      Pharmacovigilance  Forecast by Service Provider  (2017-2027)

12.4.2.      Pharmacovigilance  Market Share Forecast by Service Provider  (2017-2027)

12.5. Pharmacovigilance  Market Forecast by Type  (2017-2027)

12.5.1.      Pharmacovigilance  Forecast by Type  (2017-2027)

12.5.2.      Pharmacovigilance  Market Share Forecast by Type  (2017-2027)

12.6. Pharmacovigilance  Market Forecast by End User (2017-2027)

12.6.1.      Pharmacovigilance  Forecast by End User (2017-2027)

12.6.2.      Pharmacovigilance  Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Pharmacovigilance Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Pharmacovigilance Revenue and Revenue Share by Clinical Trial Phase (2017-2018)
Figure Global Pre-clinical Revenue and Growth Rate (2017-2018)
Figure Global Phase I Revenue and Growth Rate (2017-2018)
Figure Global Phase II Revenue and Growth Rate (2017-2018)
Figure Global Phase III Revenue and Growth Rate (2017-2018)
Figure Global Phase IV Revenue and Growth Rate (2017-2018)
Table Global Pharmacovigilance Revenue and Revenue Share by Service Provider (2017-2018)
Figure Global In-house Revenue and Growth Rate (2017-2018)
Figure Global Contract Outsourcing Revenue and Growth Rate (2017-2018)
Table Global Pharmacovigilance Revenue and Revenue Share by Type (2017-2018)
Figure Global Intensified ADR Reporting Revenue and Growth Rate (2017-2018)
Figure Global Targeted Spontaneous Reporting Revenue and Growth Rate (2017-2018)
Figure Global Spontaneous Reporting Revenue and Growth Rate (2017-2018)
Figure Global EHR Mining Revenue and Growth Rate (2017-2018)
Figure Global Cohort Event Monitoring Revenue and Growth Rate (2017-2018)
Table Global Pharmacovigilance Revenue and Revenue Share by End User (2017-2018)
Figure Global Research Organizations Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Industrial Revenue and Growth Rate (2017-2018)
Table Global Pharmacovigilance Revenue by Regions (2017-2018)
Figure North America Pharmacovigilance Growth Rate (2017-2018)
Figure North America Pharmacovigilance Revenue and Growth Rate (2017-2018)
Figure North America Pharmacovigilance by Countries (2017-2018)
Figure North America Pharmacovigilance Revenue (Million USD) by Countries (2017-2018)
Figure United States Pharmacovigilance Growth Rate (2017-2018)
Figure United States Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Pharmacovigilance Growth Rate (2017-2018)
Figure Canada Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Pharmacovigilance Growth Rate (2017-2018)
Figure Mexico Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Pharmacovigilance Growth Rate (2017-2018)
Figure Europe Pharmacovigilance Revenue and Growth Rate (2017-2018)
Figure Europe Pharmacovigilance by Countries (2017-2018)
Figure Europe Pharmacovigilance Revenue (Million USD) by Countries (2017-2018)
Figure Germany Pharmacovigilance Growth Rate (2017-2018)
Figure Germany Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Pharmacovigilance Growth Rate (2017-2018)
Figure France Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Pharmacovigilance Growth Rate (2017-2018)
Figure UK Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Pharmacovigilance Growth Rate (2017-2018)
Figure Russia Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Pharmacovigilance Growth Rate (2017-2018)
Figure Italy Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Pharmacovigilance Growth Rate (2017-2018)
Figure Rest of Europe Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Pharmacovigilance Growth Rate (2017-2018)
Figure Asia-Pacific Pharmacovigilance Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Pharmacovigilance by Countries (2017-2018)
Figure Asia-Pacific Pharmacovigilance Revenue (Million USD) by Countries (2017-2018)
Figure China Pharmacovigilance Growth Rate (2017-2018)
Figure China Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Pharmacovigilance Growth Rate (2017-2018)
Figure Japan Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Pharmacovigilance Growth Rate (2017-2018)
Figure Korea Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Pharmacovigilance Growth Rate (2017-2018)
Figure India Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Pharmacovigilance Growth Rate (2017-2018)
Figure Southeast Asia Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pharmacovigilance Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Pharmacovigilance Growth Rate (2017-2018)
Figure South America Pharmacovigilance Revenue and Growth Rate (2017-2018)
Figure South America Pharmacovigilance by Countries (2017-2018)
Figure South America Pharmacovigilance Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Pharmacovigilance Growth Rate (2017-2018)
Figure Brazil Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Pharmacovigilance Growth Rate (2017-2018)
Figure Argentina Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Pharmacovigilance Growth Rate (2017-2018)
Figure Columbia Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Pharmacovigilance Growth Rate (2017-2018)
Figure Rest of South America Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Pharmacovigilance Growth Rate (2017-2018)
Figure Middle East and Africa Pharmacovigilance Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Pharmacovigilance by Countries (2017-2018)
Figure Middle East and Africa Pharmacovigilance Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Pharmacovigilance Growth Rate (2017-2018)
Figure Saudi Arabia Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Pharmacovigilance Growth Rate (2017-2018)
Figure United Arab Emirates Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Pharmacovigilance Growth Rate (2017-2018)
Figure Egypt Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Pharmacovigilance Growth Rate (2017-2018)
Figure Nigeria Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Pharmacovigilance Growth Rate (2017-2018)
Figure South Africa Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Pharmacovigilance Growth Rate (2017-2018)
Figure Turkey Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pharmacovigilance Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pharmacovigilance Revenue (Millions USD) and Growth Rate (2017-2018)
Table BioClinica Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table LabCorp Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Capgemini Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Clinquest Group B.V Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table iMEDGlobal Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ITClinical Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cognizant Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ArisGlobal LLC Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ICON plc Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table IBM Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Accenture Pharmacovigilance Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Pharmacovigilance Market Share by Manufacturer
Figure Global Pharmacovigilance Revenue and Market Share by Manufacturer
Table Global Pharmacovigilance Price by Region (2017-2017)
Figure Top 5 Pharmacovigilance Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Pharmacovigilance Revenue (Millions USD) and Growth Rate (2018-2025)
Table Pharmacovigilance Market Forecast by Regions (2018-2025)
Figure North America Pharmacovigilance Market Forecast (2018-2025)
Figure United States Pharmacovigilance Market Forecast (2018-2025)
Figure Canada Pharmacovigilance Market Forecast (2018-2025)
Figure Mexico Pharmacovigilance Market Forecast (2018-2025)
Figure Europe Pharmacovigilance Market Forecast (2018-2025)
Figure Germany Pharmacovigilance Market Forecast (2018-2025)
Figure France Pharmacovigilance Market Forecast (2018-2025)
Figure UK Pharmacovigilance Market Forecast (2018-2025)
Figure Russia Pharmacovigilance Market Forecast (2018-2025)
Figure Italy Pharmacovigilance Market Forecast (2018-2025)
Figure Rest of Europe Pharmacovigilance Market Forecast (2018-2025)
Figure Asia-Pacific Pharmacovigilance Market Forecast (2018-2025)
Figure China Pharmacovigilance Market Forecast (2018-2025)
Figure Japan Pharmacovigilance Market Forecast (2018-2025)
Figure Korea Pharmacovigilance Market Forecast (2018-2025)
Figure India Pharmacovigilance Market Forecast (2018-2025)
Figure Southeast Asia Pharmacovigilance Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Pharmacovigilance Market Forecast (2018-2025)
Figure South America Pharmacovigilance Market Forecast (2018-2025)
Figure Brazil Pharmacovigilance Market Forecast (2018-2025)
Figure Argentina Pharmacovigilance Market Forecast (2018-2025)
Figure Columbia Pharmacovigilance Market Forecast (2018-2025)
Figure Rest of South America Pharmacovigilance Market Forecast (2018-2025)
Figure Middle East and Africa Pharmacovigilance Market Forecast (2018-2025)
Figure Saudi Arabia Pharmacovigilance Market Forecast (2018-2025)
Figure United Arab Emirates Pharmacovigilance Market Forecast (2018-2025)
Figure Egypt Pharmacovigilance Market Forecast (2018-2025)
Figure Nigeria Pharmacovigilance Market Forecast (2018-2025)
Figure South Africa Pharmacovigilance Market Forecast (2018-2025)
Figure Turkey Pharmacovigilance Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Pharmacovigilance Market Forecast (2018-2025)
Figure Global Pharmacovigilance Forecast by Clinical Trial Phase (2018-2025)
Figure Global Pharmacovigilance Market Share Forecast by Clinical Trial Phase (2018-2025)
Figure Global Pharmacovigilance Forecast by Clinical Trial Phase (2018-2025)
Figure Global Pharmacovigilance Forecast by Service Provider (2018-2025)
Figure Global Pharmacovigilance Market Share Forecast by Service Provider (2018-2025)
Figure Global Pharmacovigilance Forecast by Service Provider (2018-2025)
Figure Global Pharmacovigilance Forecast by Type (2018-2025)
Figure Global Pharmacovigilance Market Share Forecast by Type (2018-2025)
Figure Global Pharmacovigilance Forecast by Type (2018-2025)
Figure Global Pharmacovigilance Forecast by End User (2018-2025)
Figure Global Pharmacovigilance Market Share Forecast by End User (2018-2025)
Figure Global Pharmacovigilance Forecast by End User (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*